Apixaban vs rivaroxaban in patients with atrial fibrillation at high or low bleeding risk: a population-based cohort study
Shurrab M, Austin PC, Jackevicius CA, Tu K, Qiu F, Haldenby O, Davies S, Lopes RD, Baykaner T, Johnson LS, Healey JS, Ko DT. Heart Rhythm. 2024; S1547-5271(24)03151-5.